GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (NAS:CSII) » Definitions » Cyclically Adjusted PB Ratio

Cardiovascular Systems (Cardiovascular Systems) Cyclically Adjusted PB Ratio : (As of May. 06, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Cardiovascular Systems Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cardiovascular Systems Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cardiovascular Systems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems Cyclically Adjusted PB Ratio Chart

Cardiovascular Systems Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cardiovascular Systems Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cardiovascular Systems's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Cardiovascular Systems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiovascular Systems's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cardiovascular Systems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cardiovascular Systems's Cyclically Adjusted PB Ratio falls into.



Cardiovascular Systems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cardiovascular Systems's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2022 is calculated as:

For example, Cardiovascular Systems's adjusted Book Value per Share data for the three months ended in Dec. 2022 was:

Adj_Book=Book Value per Share/CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=5.704/125.2218*125.2218
=5.704

Current CPI (Dec. 2022) = 125.2218.

Cardiovascular Systems Quarterly Data

Book Value per Share CPI Adj_Book
201303 2.920 98.209 3.723
201306 2.741 98.518 3.484
201309 2.588 98.790 3.280
201312 5.241 98.326 6.675
201403 5.062 99.695 6.358
201406 4.892 100.560 6.092
201409 4.719 100.428 5.884
201412 4.693 99.070 5.932
201503 4.501 99.621 5.658
201506 4.371 100.684 5.436
201509 4.026 100.392 5.022
201512 3.705 99.792 4.649
201603 3.114 100.470 3.881
201606 3.077 101.688 3.789
201609 3.115 101.861 3.829
201612 3.440 101.863 4.229
201703 3.470 102.862 4.224
201706 3.604 103.349 4.367
201709 3.518 104.136 4.230
201712 3.732 104.011 4.493
201803 3.802 105.290 4.522
201806 4.031 106.317 4.748
201809 3.861 106.507 4.539
201812 3.980 105.998 4.702
201903 4.066 107.251 4.747
201906 4.235 108.070 4.907
201909 4.036 108.329 4.665
201912 4.065 108.420 4.695
202003 4.059 108.902 4.667
202006 6.775 108.767 7.800
202009 6.689 109.815 7.627
202012 6.813 109.897 7.763
202103 6.734 111.754 7.546
202106 6.738 114.631 7.361
202109 6.485 115.734 7.017
202112 6.393 117.630 6.806
202203 6.216 121.301 6.417
202206 6.090 125.017 6.100
202209 5.780 125.227 5.780
202212 5.704 125.222 5.704

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cardiovascular Systems  (NAS:CSII) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cardiovascular Systems Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiovascular Systems (Cardiovascular Systems) Business Description

Traded in Other Exchanges
N/A
Address
1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.
Executives
Jeffrey S. Points officer: Chief Financial Officer C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Scott R Ward director RAYMOND HOLDINGS, LLC, 6410 BALLANTINE CT., INVER GROVE HEIGHTS MN 55077
Erik Paulsen director C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Rhonda J. Robb officer: Chief Operating Officer C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Martha Goldberg Aronson director 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Sachin H. Jain director C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Alexander Rosenstein officer: General Counsel & Corp. Secy C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Sandra Sedo officer: Chief Compliance Officer C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Kelvin K. Womack director C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Stephen J. Rempe officer: Chief Human Resources Officer C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
John M. Hastings officer: VP Manufacturing & Operations C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Stephen Stenbeck director C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Ryan Egeland officer: VP of Medical Affairs C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
David Whitescarver officer: VP of Corp. Dev. & IP C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Laura Gillund officer: Chief Talent Officer

Cardiovascular Systems (Cardiovascular Systems) Headlines

From GuruFocus

Cytek Biosciences Set to Join S&P SmallCap 600

By PRNewswire PRNewswire 04-25-2023